{"id":1557,"date":"2019-10-02T00:00:00","date_gmt":"2019-10-01T22:00:00","guid":{"rendered":"http:\/\/idlbiotech.com\/?p=1557"},"modified":"2021-05-26T09:17:37","modified_gmt":"2021-05-26T07:17:37","slug":"idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics","status":"publish","type":"post","link":"https:\/\/idldiagnostics.com\/se\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/","title":{"rendered":"IDL Biotech licensierar sin produktlinje f\u00f6r tum\u00f6rmark\u00f6rer p\u00e5 den manuella plattformen radioimmunoassay till Beckman Coulter Diagnostics"},"content":{"rendered":"<p>IDL Biotech meddelar att de har tecknat ett avtal med Beckman Coulter om licensiering av IDL Biotechs samtliga tum\u00f6rmark\u00f6rer p\u00e5 den manuella plattformen radioimmunoassay (IRMA). Licensavtalet ger Beckman Coulter globala f\u00f6rs\u00e4ljningsr\u00e4ttigheter och m\u00f6jligg\u00f6r f\u00f6r IDL att erh\u00e5lla royalties. Avtalet har formellt undertecknats av Immunotech, ett dotterbolag till Beckman Coulter.<\/p>\n<p>L\u00e4s pressmeddelandet <em><strong><a href=\"https:\/\/spotlightstockmarket.com\/sv\/market-overview\/nyheter\/\/nyhets-artikel?id=53257\">h\u00e4r.&nbsp;<\/a><\/strong><\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>IDL Biotech meddelar att de har tecknat ett avtal med Beckman Coulter om licensiering av IDL Biotechs samtliga tum\u00f6rmark\u00f6rer p\u00e5 den manuella plattformen radioimmunoassay (IRMA). Licensavtalet ger Beckman Coulter globala f\u00f6rs\u00e4ljningsr\u00e4ttigheter och m\u00f6jligg\u00f6r f\u00f6r IDL att erh\u00e5lla royalties. Avtalet har formellt undertecknats av Immunotech, ett dotterbolag till Beckman Coulter. L\u00e4s pressmeddelandet h\u00e4r.&nbsp;<\/p>","protected":false},"author":11,"featured_media":2579,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[11],"tags":[],"dipi_cpt_category":[],"class_list":["post-1557","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IDL Biotech licensierar sin produktlinje f\u00f6r tum\u00f6rmark\u00f6rer p\u00e5 den manuella plattformen radioimmunoassay till Beckman Coulter Diagnostics - IDL Diagnostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/idldiagnostics.com\/se\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IDL Biotech licensierar sin produktlinje f\u00f6r tum\u00f6rmark\u00f6rer p\u00e5 den manuella plattformen radioimmunoassay till Beckman Coulter Diagnostics - IDL Diagnostics\" \/>\n<meta property=\"og:description\" content=\"IDL Biotech meddelar att de har tecknat ett avtal med Beckman Coulter om licensiering av IDL Biotechs samtliga tum\u00f6rmark\u00f6rer p\u00e5 den manuella plattformen radioimmunoassay (IRMA). Licensavtalet ger Beckman Coulter globala f\u00f6rs\u00e4ljningsr\u00e4ttigheter och m\u00f6jligg\u00f6r f\u00f6r IDL att erh\u00e5lla royalties. Avtalet har formellt undertecknats av Immunotech, ett dotterbolag till Beckman Coulter. L\u00e4s pressmeddelandet h\u00e4r.&nbsp;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/idldiagnostics.com\/se\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/\" \/>\n<meta property=\"og:site_name\" content=\"IDL Diagnostics\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/arocell\" \/>\n<meta property=\"article:published_time\" content=\"2019-10-01T22:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-26T07:17:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/idl-film3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"arocell\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"arocell\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2019\\\/10\\\/02\\\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2019\\\/10\\\/02\\\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\\\/\"},\"author\":{\"name\":\"arocell\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/person\\\/216cc1ee3aba5d7b9428e35b4dc70404\"},\"headline\":\"IDL Biotech licensierar sin produktlinje f\u00f6r tum\u00f6rmark\u00f6rer p\u00e5 den manuella plattformen radioimmunoassay till Beckman Coulter Diagnostics\",\"datePublished\":\"2019-10-01T22:00:00+00:00\",\"dateModified\":\"2021-05-26T07:17:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2019\\\/10\\\/02\\\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\\\/\"},\"wordCount\":83,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2019\\\/10\\\/02\\\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/idl-film3.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/2019\\\/10\\\/02\\\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2019\\\/10\\\/02\\\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/2019\\\/10\\\/02\\\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\\\/\",\"name\":\"IDL Biotech licensierar sin produktlinje f\u00f6r tum\u00f6rmark\u00f6rer p\u00e5 den manuella plattformen radioimmunoassay till Beckman Coulter Diagnostics - IDL Diagnostics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2019\\\/10\\\/02\\\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2019\\\/10\\\/02\\\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/idl-film3.png\",\"datePublished\":\"2019-10-01T22:00:00+00:00\",\"dateModified\":\"2021-05-26T07:17:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2019\\\/10\\\/02\\\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/2019\\\/10\\\/02\\\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2019\\\/10\\\/02\\\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/idl-film3.png\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/idl-film3.png\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2019\\\/10\\\/02\\\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IDL Biotech licensierar sin produktlinje f\u00f6r tum\u00f6rmark\u00f6rer p\u00e5 den manuella plattformen radioimmunoassay till Beckman Coulter Diagnostics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"name\":\"IDL Diagnostics\",\"description\":\"Saving lives with diagnostics\",\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/idldiagnostics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\",\"name\":\"IDL Diagnostics\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"width\":1713,\"height\":570,\"caption\":\"IDL Diagnostics\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/arocell\",\"https:\\\/\\\/linkedin.com\\\/company\\\/arocell\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/person\\\/216cc1ee3aba5d7b9428e35b4dc70404\",\"name\":\"arocell\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c7bb5bab8923419e09dae74adec3dfc4637cb79c67b5482d014aa1002eae437f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c7bb5bab8923419e09dae74adec3dfc4637cb79c67b5482d014aa1002eae437f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c7bb5bab8923419e09dae74adec3dfc4637cb79c67b5482d014aa1002eae437f?s=96&d=mm&r=g\",\"caption\":\"arocell\"},\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/se\\\/author\\\/arocell\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IDL Biotech licensierar sin produktlinje f\u00f6r tum\u00f6rmark\u00f6rer p\u00e5 den manuella plattformen radioimmunoassay till Beckman Coulter Diagnostics - IDL Diagnostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/idldiagnostics.com\/se\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/","og_locale":"sv_SE","og_type":"article","og_title":"IDL Biotech licensierar sin produktlinje f\u00f6r tum\u00f6rmark\u00f6rer p\u00e5 den manuella plattformen radioimmunoassay till Beckman Coulter Diagnostics - IDL Diagnostics","og_description":"IDL Biotech meddelar att de har tecknat ett avtal med Beckman Coulter om licensiering av IDL Biotechs samtliga tum\u00f6rmark\u00f6rer p\u00e5 den manuella plattformen radioimmunoassay (IRMA). Licensavtalet ger Beckman Coulter globala f\u00f6rs\u00e4ljningsr\u00e4ttigheter och m\u00f6jligg\u00f6r f\u00f6r IDL att erh\u00e5lla royalties. Avtalet har formellt undertecknats av Immunotech, ett dotterbolag till Beckman Coulter. L\u00e4s pressmeddelandet h\u00e4r.&nbsp;","og_url":"https:\/\/idldiagnostics.com\/se\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/","og_site_name":"IDL Diagnostics","article_publisher":"https:\/\/www.facebook.com\/arocell","article_published_time":"2019-10-01T22:00:00+00:00","article_modified_time":"2021-05-26T07:17:37+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/idl-film3.png","type":"image\/png"}],"author":"arocell","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"arocell"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/idldiagnostics.com\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/#article","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/"},"author":{"name":"arocell","@id":"https:\/\/idldiagnostics.com\/#\/schema\/person\/216cc1ee3aba5d7b9428e35b4dc70404"},"headline":"IDL Biotech licensierar sin produktlinje f\u00f6r tum\u00f6rmark\u00f6rer p\u00e5 den manuella plattformen radioimmunoassay till Beckman Coulter Diagnostics","datePublished":"2019-10-01T22:00:00+00:00","dateModified":"2021-05-26T07:17:37+00:00","mainEntityOfPage":{"@id":"https:\/\/idldiagnostics.com\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/"},"wordCount":83,"commentCount":0,"publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"image":{"@id":"https:\/\/idldiagnostics.com\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/#primaryimage"},"thumbnailUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/idl-film3.png","articleSection":["News"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/idldiagnostics.com\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/idldiagnostics.com\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/","url":"https:\/\/idldiagnostics.com\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/","name":"IDL Biotech licensierar sin produktlinje f\u00f6r tum\u00f6rmark\u00f6rer p\u00e5 den manuella plattformen radioimmunoassay till Beckman Coulter Diagnostics - IDL Diagnostics","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/idldiagnostics.com\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/#primaryimage"},"image":{"@id":"https:\/\/idldiagnostics.com\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/#primaryimage"},"thumbnailUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/idl-film3.png","datePublished":"2019-10-01T22:00:00+00:00","dateModified":"2021-05-26T07:17:37+00:00","breadcrumb":{"@id":"https:\/\/idldiagnostics.com\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/idldiagnostics.com\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/#primaryimage","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/idl-film3.png","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/idl-film3.png","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/idldiagnostics.com\/2019\/10\/02\/idl-biotech-ab-idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-plattformen-radioimmunoassay-till-beckman-coulter-diagnostics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/idldiagnostics.com\/"},{"@type":"ListItem","position":2,"name":"IDL Biotech licensierar sin produktlinje f\u00f6r tum\u00f6rmark\u00f6rer p\u00e5 den manuella plattformen radioimmunoassay till Beckman Coulter Diagnostics"}]},{"@type":"WebSite","@id":"https:\/\/idldiagnostics.com\/#website","url":"https:\/\/idldiagnostics.com\/","name":"IDL Diagnostik","description":"R\u00e4dda liv med diagnostik","publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/idldiagnostics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/idldiagnostics.com\/#organization","name":"IDL Diagnostik","url":"https:\/\/idldiagnostics.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","width":1713,"height":570,"caption":"IDL Diagnostics"},"image":{"@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/arocell","https:\/\/linkedin.com\/company\/arocell"]},{"@type":"Person","@id":"https:\/\/idldiagnostics.com\/#\/schema\/person\/216cc1ee3aba5d7b9428e35b4dc70404","name":"arocell","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/c7bb5bab8923419e09dae74adec3dfc4637cb79c67b5482d014aa1002eae437f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c7bb5bab8923419e09dae74adec3dfc4637cb79c67b5482d014aa1002eae437f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c7bb5bab8923419e09dae74adec3dfc4637cb79c67b5482d014aa1002eae437f?s=96&d=mm&r=g","caption":"arocell"},"url":"https:\/\/idldiagnostics.com\/se\/author\/arocell\/"}]}},"_links":{"self":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/1557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/comments?post=1557"}],"version-history":[{"count":2,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/1557\/revisions"}],"predecessor-version":[{"id":2682,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/1557\/revisions\/2682"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media\/2579"}],"wp:attachment":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media?parent=1557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/categories?post=1557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/tags?post=1557"},{"taxonomy":"dipi_cpt_category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/dipi_cpt_category?post=1557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}